309 related articles for article (PubMed ID: 35623698)
1. Emerging mechanisms of targeted protein degradation by molecular glues.
Frere GA; de Araujo ED; Gunning PT
Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
[TBL] [Abstract][Full Text] [Related]
2. Clinical Translation of Targeted Protein Degraders.
Kong NR; Jones LH
Clin Pharmacol Ther; 2023 Sep; 114(3):558-568. PubMed ID: 37399310
[TBL] [Abstract][Full Text] [Related]
3. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
[TBL] [Abstract][Full Text] [Related]
4. Haven't got a glue: Protein surface variation for the design of molecular glue degraders.
Kozicka Z; Thomä NH
Cell Chem Biol; 2021 Jul; 28(7):1032-1047. PubMed ID: 33930325
[TBL] [Abstract][Full Text] [Related]
5. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
Kastl JM; Davies G; Godsman E; Holdgate GA
SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
[TBL] [Abstract][Full Text] [Related]
6. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
Belcher BP; Ward CC; Nomura DK
Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
[TBL] [Abstract][Full Text] [Related]
7. Induced protein degradation for therapeutics: past, present, and future.
Yoon H; Rutter JC; Li YD; Ebert BL
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 38165043
[TBL] [Abstract][Full Text] [Related]
8. From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation.
Oleinikovas V; Gainza P; Ryckmans T; Fasching B; Thomä NH
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():291-312. PubMed ID: 37585660
[TBL] [Abstract][Full Text] [Related]
9. Biophysical and Computational Approaches to Study Ternary Complexes: A 'Cooperative Relationship' to Rationalize Targeted Protein Degradation.
Ward JA; Perez-Lopez C; Mayor-Ruiz C
Chembiochem; 2023 May; 24(10):e202300163. PubMed ID: 37018140
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders.
Przytulski K; Glaza P; Brach K; Sagan M; Statkiewicz G; Klajn J; Walczak MJ
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130398. PubMed ID: 37301332
[TBL] [Abstract][Full Text] [Related]
11. Chasing molecular glue degraders: screening approaches.
Domostegui A; Nieto-Barrado L; Perez-Lopez C; Mayor-Ruiz C
Chem Soc Rev; 2022 Jul; 51(13):5498-5517. PubMed ID: 35723413
[TBL] [Abstract][Full Text] [Related]
12. Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic.
Sasso JM; Tenchov R; Wang D; Johnson LS; Wang X; Zhou QA
Biochemistry; 2023 Feb; 62(3):601-623. PubMed ID: 35856839
[TBL] [Abstract][Full Text] [Related]
13. Emerging strategies for prospective discovery of molecular glue degraders.
Wang B; Cao S; Zheng N
Curr Opin Struct Biol; 2024 Jun; 86():102811. PubMed ID: 38598983
[TBL] [Abstract][Full Text] [Related]
14. Key Considerations in Targeted Protein Degradation Drug Discovery and Development.
Qin L; Dai H; Wang J
Front Chem; 2022; 10():934337. PubMed ID: 35978859
[TBL] [Abstract][Full Text] [Related]
15. Advancing targeted protein degrader discovery by measuring cereblon engagement in cells.
Zerfas BL; Huerta F; Liu H; Du G; Gray NS; Jones LH; Nowak RP
Methods Enzymol; 2023; 681():169-188. PubMed ID: 36764756
[TBL] [Abstract][Full Text] [Related]
16. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
Cowan AD; Ciulli A
Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
[TBL] [Abstract][Full Text] [Related]
17. E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor Abundance.
Hanzl A; Barone E; Bauer S; Yue H; Nowak RP; Hahn E; Pankevich EV; Koren A; Kubicek S; Fischer ES; Winter GE
J Am Chem Soc; 2023 Jan; 145(2):1176-1184. PubMed ID: 36602777
[TBL] [Abstract][Full Text] [Related]
18. Targeted protein degradation via intramolecular bivalent glues.
Hsia O; Hinterndorfer M; Cowan AD; Iso K; Ishida T; Sundaramoorthy R; Nakasone MA; Imrichova H; Schätz C; Rukavina A; Husnjak K; Wegner M; Correa-Sáez A; Craigon C; Casement R; Maniaci C; Testa A; Kaulich M; Dikic I; Winter GE; Ciulli A
Nature; 2024 Mar; 627(8002):204-211. PubMed ID: 38383787
[TBL] [Abstract][Full Text] [Related]
19. Design principles for cyclin K molecular glue degraders.
Kozicka Z; Suchyta DJ; Focht V; Kempf G; Petzold G; Jentzsch M; Zou C; Di Genua C; Donovan KA; Coomar S; Cigler M; Mayor-Ruiz C; Schmid-Burgk JL; Häussinger D; Winter GE; Fischer ES; Słabicki M; Gillingham D; Ebert BL; Thomä NH
Nat Chem Biol; 2024 Jan; 20(1):93-102. PubMed ID: 37679459
[TBL] [Abstract][Full Text] [Related]
20. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.
Riching KM; Caine EA; Urh M; Daniels DL
Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
